Release Date: 22/05/23 17:57 Summary: RMS: Breaker offer status and compulsory acquisition notice Price Sensitive: Yes Download Document 519.29KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%